Brown Brothers Harriman & Co. decreased its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 17.3% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 9,227 shares of the company’s stock after selling 1,928 shares during the period. Brown Brothers Harriman & Co.’s holdings in Thermo Fisher Scientific were worth $1,468,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Mycio Wealth Partners LLC raised its stake in Thermo Fisher Scientific by 1.6% in the second quarter. Mycio Wealth Partners LLC now owns 711 shares of the company’s stock worth $105,000 after buying an additional 11 shares in the last quarter. Parsec Financial Management Inc. raised its stake in Thermo Fisher Scientific by 0.6% in the third quarter. Parsec Financial Management Inc. now owns 1,938 shares of the company’s stock worth $308,000 after buying an additional 12 shares in the last quarter. Quadrant Capital Group LLC raised its stake in Thermo Fisher Scientific by 0.6% in the third quarter. Quadrant Capital Group LLC now owns 2,844 shares of the company’s stock worth $442,000 after buying an additional 18 shares in the last quarter. Savant Capital LLC raised its stake in Thermo Fisher Scientific by 1.2% in the third quarter. Savant Capital LLC now owns 1,718 shares of the company’s stock worth $273,000 after buying an additional 20 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC raised its stake in Thermo Fisher Scientific by 0.7% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 3,079 shares of the company’s stock worth $490,000 after buying an additional 21 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.22% during midday trading on Friday, hitting $146.29. 1,839,728 shares of the company traded hands. The stock has a market capitalization of $57.79 billion, a P/E ratio of 29.24 and a beta of 1.17. The company has a 50-day moving average price of $143.18 and a 200-day moving average price of $150.33. Thermo Fisher Scientific Inc has a 52 week low of $119.75 and a 52 week high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.06. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The firm earned $4.49 billion during the quarter, compared to analysts’ expectations of $4.39 billion. During the same quarter in the prior year, the company earned $1.80 EPS. The company’s revenue was up 8.9% compared to the same quarter last year. Analysts anticipate that Thermo Fisher Scientific Inc will post $8.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 16th. Investors of record on Thursday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, December 13th. This represents a $0.60 dividend on an annualized basis and a yield of 0.41%. Thermo Fisher Scientific’s payout ratio is 12.00%.

TRADEMARK VIOLATION NOTICE: This piece of content was first published by Daily Political and is the propert of of Daily Political. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of international copyright and trademark legislation. The legal version of this piece of content can be read at http://www.dailypolitical.com/2017/01/13/brown-brothers-harriman-co-sells-1928-shares-of-thermo-fisher-scientific-inc-tmo.html.

A number of analysts have recently weighed in on the stock. Leerink Swann assumed coverage on shares of Thermo Fisher Scientific in a report on Thursday, November 10th. They set an “outperform” rating and a $175.00 target price for the company. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday, December 14th. Goldman Sachs Group, Inc. (The) reiterated a “conviction-buy” rating and set a $168.00 target price (down from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. J P Morgan Chase & Co began coverage on shares of Thermo Fisher Scientific in a report on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 price objective for the company. Finally, Bank of America set a $180.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Friday, October 7th. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $165.22.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.